SkinHealth Systems Inc. (SKIN) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $3.57M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.80M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.24M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.70M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $3.57M | (m) | $72.11M | (m) | $427.00K* | $2.67M* | (m) | $1.41M | (m) | $1.21M |
| 2026-03-31 | Reported | (m) | -$1.80M | (m) | $64.91M | (m) | $224.00K | -$5.55M | (m) | $1.10M | (m) | -$184.00K |
| 2025-09-30 | Reported | (m) | -$6.24M | (m) | $70.66M | (m) | $27.00K* | $9.65M* | (m) | $1.70M | (m) | $386.00K |
| 2025-06-30 | Reported | (m) | -$2.70M | (m) | $78.19M | (m) | $92.00K* | $9.65M* | (m) | $1.25M | (m) | -$993.00K |
| 2025-03-31 | Reported | (m) | -$12.02M | (m) | $69.58M | (m) | $45.00K | $3.00M | (m) | $998.00K | (m) | $892.00K |
| 2024-09-30 | Reported | (m) | -$21.52M | (m) | $78.80M | (m) | $4.00K* | $10.31M* | (m) | $1.11M | (m) | $1.95M |
| 2024-06-30 | Reported | (m) | -$22.11M | (m) | $90.59M | (m) | $334.00K* | $6.20M* | (m) | $1.16M | (m) | -$353.00K |
| 2024-03-31 | Reported | (m) | -$16.99M | (m) | $81.40M | (m) | $344.00K | -$16.85M | (m) | $2.81M | (m) | -$659.00K |
| 2023-09-30 | Reported | (m) | -$82.10M | (m) | $97.41M | (m) | $174.00K* | $17.96M* | (m) | $1.84M | (m) | $3.48M |
| 2023-06-30 | Reported | (m) | -$13.15M | (m) | $117.48M | (m) | $1.30M* | $21.97M* | (m) | $2.88M | (m) | -$2.19M |
| 2023-03-31 | Reported | (m) | -$17.31M | (m) | $86.28M | (m) | $2.32M | -$13.01M | (m) | $2.34M | (m) | -$3.66M |
| 2022-09-30 | Reported | (m) | -$4.35M | (m) | $88.79M | (m) | $4.30M* | -$31.40M* | (m) | $2.17M | (m) | -$821.00K |
| 2022-06-30 | Reported | (m) | -$5.03M | (m) | $103.54M | (m) | $2.43M* | -$31.34M* | (m) | $2.60M | (m) | $76.00K |
| 2022-03-31 | Reported | (m) | -$14.01M | (m) | $75.42M | (m) | $3.15M | -$38.47M | (m) | $2.23M | (m) | $2.62M |
| 2021-09-30 | Reported | (m) | -$5.46M | (m) | $68.15M | (m) | $150.00K* | $298.00K* | (m) | $1.88M | (m) | -$1.13M |
| 2021-06-30 | Reported | (m) | -$26.35M | (m) | $66.51M | (m) | $3.89M* | -$33.20M* | (m) | $2.99M | (m) | -$1.87M |
| 2021-03-31 | Reported | (m) | $2.38M | (m) | $47.54M | (m) | $818.00K | $1.26M | (m) | $1.45M | (m) | -$306.00K |
| 2020-09-30 | Reported | (m) | $2.79M | (m) | $34.56M | (m) | $1.27M* | -$392.00K* | (m) | $577.00K | (m) | -$593.00K |
| 2020-06-30 | Reported | (m) | -$7.92M | (m) | $14.12M | (m) | (m) | (m) | (m) | $597.00K | (m) | -$3.05M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$20.80M | (m) | $300.79M | (m) | $303.00K | $37.48M | (m) | $5.63M | (m) | $3.58M |
| 2024-12-31 | Reported | (m) | -$67.77M | (m) | $334.29M | (m) | $756.00K | $16.13M | (m) | $6.30M | (m) | -$452.00K |
| 2023-12-31 | Reported | (m) | -$130.92M | (m) | $397.99M | (m) | $3.83M | $21.75M | (m) | $10.10M | (m) | -$1.77M |
| 2022-12-31 | Reported | (m) | -$25.84M | (m) | $365.88M | (m) | $10.85M | -$106.60M | (m) | $8.44M | (m) | $1.11M |
| 2021-12-31 | Reported | (m) | -$39.93M | (m) | $260.09M | (m) | $11.20M | -$28.36M | (m) | $8.20M | (m) | -$1.88M |
| 2020-12-31 | Reported | (m) | -$17.18M | (m) | $119.09M | (m) | $3.50M | -$12.44M | (m) | $3.41M | (m) | -$9.31M |
| 2019-12-31 | Reported | (m) | $13.46M | (m) | $166.62M | (m) | $8.77M | $1.73M | (m) | $4.61M | (m) | -$1.30M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |